Arrowhead Research | Beneficio Operativo



Operating Profit Cambio Fecha
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Incyte USD 301.51M 155.43M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
Ligand Pharmaceuticals USD -9637000 5.07B 2024-12
Merck USD 4.3B 369M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Novartis USD 2.28B 1.34B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Xencor USD 4.05M 66.33M 2024-12



Arrowhead Research Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.